# PDT Plus Vitamin D3 for Anal Dysplasia

> **NCT02698293** · PHASE1 · WITHDRAWN · sponsor: **Abramson Cancer Center at Penn Medicine**

## Conditions studied

- Anal Dysplasia
- Carcinoma in Situ

## Interventions

- **DRUG:** Gliolan
- **DRUG:** Vitamin D3 cholecalciferol)
- **OTHER:** Photodynamic Therpay

## Key facts

- **NCT ID:** NCT02698293
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-12-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Covid-19
- **Last updated:** 2022-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02698293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02698293, "PDT Plus Vitamin D3 for Anal Dysplasia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02698293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*